compared to KUB alone without a concomitant significant increase in false positives. Further studies will determine the true cost and radiation savings associated with the use of this technology, but it appears to be a promising imaging modality for urinary stones and a possible alternative to NCCT in some settings. The maximum stone dimension in the axial reconstruction and stone location are often used to estimate the probability of spontaneous stone passage and potential likelihood of surgical intervention. However, the measured axial dimension of urinary stones can vary considerably owing to irregular shape, obliquity to the imaging plane, non-isotropic imaging voxels, interobserver variability, and volume averaging. This limits the reproducibility of axial stone measurements and the accuracy of predictions based upon maximum axial stone dimension. The present study compared the standard measures of stone size from axial images to those obtained using dedicated stone analysis software, which determined maximal stone dimensions in all planes.
INTRODUCTION AND OBJECTIVES: Computed Tomography
(CT) is a clinically established modality to evaluate suspected urinary stones. The maximum stone dimension in the axial reconstruction and stone location are often used to estimate the probability of spontaneous stone passage and potential likelihood of surgical intervention. However, the measured axial dimension of urinary stones can vary considerably owing to irregular shape, obliquity to the imaging plane, non-isotropic imaging voxels, interobserver variability, and volume averaging. This limits the reproducibility of axial stone measurements and the accuracy of predictions based upon maximum axial stone dimension. The present study compared the standard measures of stone size from axial images to those obtained using dedicated stone analysis software, which determined maximal stone dimensions in all planes.
METHODS: Non-contrast-enhanced abdominal CT scans from 211 consecutive emergency department patients performed to evaluate flank were retrospectively evaluated. Radiological reports were reviewed for a diagnosis of urolithiasis, the maximum axial stone dimension, and stone location. Corresponding 1 mm thick images were analyzed using dedicated stone analysis software to compute the maximum linear dimension in any direction and stone volume. Descriptive outcomes are reported here (mean (SD)), comparing traditional maximum axial dimension and stone volume (assuming a spherical stone) to measurements made using dedicated software that performed 3D stone segmentation.
RESULTS: A total of 228 stones were identified in 143 of the 211 patients. The mean maximum dimension in any direction computed by the software algorithm was 5.0 (3.2) mm, which was significantly higher than the mean maximum dimension of 3.9 (2.9) mm contained in the radiographic reports (p¼0.0002). The actual stone volume computed by the algorithm based upon the true stone dimensions and shape was 52.8 (141.5) mm3, while the stone volume calculated assuming a spherical shape was 31.06 (102.16) mm3 (p¼0.0628).
CONCLUSIONS: Using dedicated stone analysis software, maximal stone dimension in any plane and stone volume were significantly larger than traditional measurements made in the axial plane and the associated volume. Semi-automated 3D measurements of stone size hence may be more accurate and reproducible. Further studies are needed to determine if automated 3D stone size metrics offer improved and more reliable prediction of spontaneous stone passage.
Source of Funding: Mayo Clinic Urolithiasis O'Brien Grant

MP01-09 IMPLEMENTING ULTRASOUND AND KIDNEY, URETER, BLADDER FILM AS FIRST-LINE IMAGING REQUIREMENTS FOR PATIENTS WITH KNOWN URINARY CALCULOUS DISEASE IN AN OUTPATIENT SETTING
Robert Medairos, M. Ryan Farrell*, Chicago, IL; Jacob Hess, Deborah Lamm, Christopher Buckle, Deerfield, IL; Christopher Coogan, Chicago, IL INTRODUCTION AND OBJECTIVES: American Urological Association guidelines recommend a combination of ultrasound (US) and kidney, ureter, bladder film (KUB) for monitoring patients with known ureteral calculous disease. We implemented a protocol of KUB and US for patients with known renal and/or ureteral calculous disease to investigate the subsequent use of computed tomography (CT) imaging and 90-day outcomes.
METHODS: We conducted a retrospective review of patients who presented in an outpatient setting with a known ICD-9 diagnosis of renal and/or ureteral calculous disease whose evaluation involved a request for CT imaging. Included patients presented between November 1, 2013 and May 31, 2014, were non-pregnant adults (>18 years old), and had no US or KUB within 60 days of CT imaging request. CT requests were sent to a specialty benefits management company (SBM), from which the data were obtained, and a third party payer. For CT imaging to be approved, the SBM required US or KUB within 60 days prior to CT imaging request. Two cohorts were evaluated: 1) approved initial CT (iCT) request and 2) redirected CT request to initial US or KUB (iUS/KUB). Requests for the iCT cohort were approved because providers attested to prior US or KUB within 60 days, while CT imaging requests for the iUS/KUB cohort were redirected because providers did not attest to prior US or KUB within 60 days. Subsequent 90-day outcomes were analyzed including need for further CT imaging, emergency department (ED) visits, and hospitalizations.
RESULTS: A total of 1307 patients were evaluated. The iUS/ KUB cohort (n¼447) underwent a significantly lower percentage of CT scans compared to the iCT cohort (n¼860) (43.8% vs. 52.1%, p<0.005). There were no significant differences between the iUS/KUB and iCT cohorts in subsequent ED visits (7.4% vs. 6.7%, p¼0.67) or hospitalizations (13.6% vs. 15.0%, p¼0.51).
CONCLUSIONS: The use of US or KUB for outpatients with known renal and/or ureteral calculous disease was associated with reduced utilization of CT imaging without significantly affecting 90-day ED visits or hospitalizations compared with patients undergoing CT alone. These results may contribute to reducing the effective dose of radiation delivered to patients and may optimize resource utilization while maintaining similar patient outcomes. Approximately half of 24-hour urine collections in prior studies have been found to be outside the accepted cutoffs with urinary creatinine to weight ratio. Our study objective was to evaluate the relationship between measured urinary creatinine and lean body mass calculated 24-hour creatinine excretion based to improve accuracy for the evaluation of 24-hour urine collection adequacy.
METHODS: This was a retrospective evaluation of 24-hour urine collections for 1319 unique nephrolithiasis patients. An established formula (figure 1c) previously to estimate urinary creatinine based on lean body mass was applied all patients in our cohort (Yu et al). We divided our cohort into two equal partitions (training and validation datasets) using a random number generator. Linear regression was used to quantify the relationship between the calculated and measured urinary creatinine in our training dataset. We then applied this relationship to our validation dataset. Two standard deviations from the expected value was considered an 00 abnormal 00 24-hour urine collection. This regression-based approach was then compared with the standard method of verifying 24-hour urine adequacy.
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